Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals (AERI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 942,209
  • Shares Outstanding, K 45,939
  • Annual Sales, $ 24,180 K
  • Annual Income, $ -232,570 K
  • 60-Month Beta 0.53
  • Price/Sales 40.37
  • Price/Cash Flow N/A
  • Price/Book 6.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.87
  • Number of Estimates 5
  • High Estimate -0.60
  • Low Estimate -1.10
  • Prior Year -1.73
  • Growth Rate Est. (year over year) +49.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.51 +17.13%
on 10/10/19
24.18 -15.18%
on 09/23/19
-1.13 (-5.22%)
since 09/18/19
3-Month
17.51 +17.13%
on 10/10/19
25.76 -20.38%
on 08/13/19
-3.11 (-13.17%)
since 07/18/19
52-Week
17.51 +17.13%
on 10/10/19
60.04 -65.84%
on 10/23/18
-37.74 (-64.79%)
since 10/18/18

Most Recent Stories

More News
Shares of Aerie Pharmaceut Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (AERI , NKTR , DERM , SUPN , PRGO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AERI : 20.51 (-3.48%)
DERM : 7.16 (+25.83%)
NKTR : 17.27 (-2.81%)
Watch for Aerie Pharmaceut to Potentially Rebound After Falling 1.49% Yesterday

Aerie Pharmaceut (NASDAQ:AERI) traded in a range yesterday that spanned from a low of $18.13 to a high of $19.08. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of...

AERI : 20.51 (-3.48%)
Aerie Pharmaceuticals Announces Appointment of Charlene E. Davis, Esq., as Vice President and Chief Compliance Officer

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 20.51 (-3.48%)
Aerie Pharmaceut is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (AERI , NKTR , MRK , BMY , CTLT )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

AERI : 20.51 (-3.48%)
MRK : 84.68 (+1.05%)
NKTR : 17.27 (-2.81%)
After Yesterday's Rally of 3.10% Shares Could Potentially Pullback

Aerie Pharmaceut (NASDAQ:AERI) traded in a range yesterday that spanned from a low of $19.03 to a high of $19.95. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high...

AERI : 20.51 (-3.48%)
Medicines Comp has the Best Relative Performance in the Pharmaceuticals Industry (MDCO , AERI , PRGO , ZGNX , SUPN )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AERI : 20.51 (-3.48%)
MDCO : 56.99 (+1.79%)
PRGO : 53.90 (-0.90%)
Aerie Pharmaceuticals to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 20.51 (-3.48%)
Watch for Aerie Pharmaceut to Potentially Pullback After Gaining 2.66% Yesterday

Aerie Pharmaceut (NASDAQ:AERI) traded in a range yesterday that spanned from a low of $23.21 to a high of $24.15. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high...

AERI : 20.51 (-3.48%)
Aerie Secures Positive CHMP Opinion for Eye Drug Rhokiinsa

The CHMP recommends Aerie's (AERI) marketing application for Rhokiinsa to reduce elevated intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension.

PFE : 36.46 (unch)
FGEN : 38.80 (-4.22%)
AERI : 20.51 (-3.48%)
BHC : 22.54 (-1.14%)
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa(R) in the European Union

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 20.51 (-3.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade AERI with:

Business Summary

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are...

See More

Key Turning Points

2nd Resistance Point 22.08
1st Resistance Point 21.30
Last Price 20.51
1st Support Level 19.85
2nd Support Level 19.18

See More

52-Week High 60.04
Fibonacci 61.8% 43.80
Fibonacci 50% 38.78
Fibonacci 38.2% 33.76
Last Price 20.51
52-Week Low 17.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar